Related Experiment Video
Updated: Jul 8, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
EspB and HtpG interact with the type III-A CRISPR/Cas system of Mycobacterium tuberculosis
Mingmin Shi1,2, Hongtai Zhang3, Joy Fleming2
1Foshan Fourth People's Hospital, Foshan, China.
Abstract:
Introduction: Mycobacterium tuberculosis (MTB) has a type III-A clustered regularly interspaced short palindromic repeat/CRISPR-associated protein (CRISPR/Cas) system consisting of a Csm1-5 and CRISPR RNA (crRNA) complex involved in the defense against invading nucleic acids. However, CRISPR/Cas system in the MTB still is clearly unknown and needs to be further explored. Methods: In our work, two non-Cas system proteins EspB and HtpG protein were found and identified by LC-MS/MS. The effect of EspB and HtpG on Type III-A CRISPR/Cas System of M. tuberculosis was examined by using Plasmid interference assay and Co-immunoprecipitation analyses. We explored that EspB could interact with the crRNA RNP complex, but HtpG could inhibit the accumulation of the MTB Csm proteins and defense the mechanism of CRISPR/Cas system. Results: The proteins ESAT-6 secretion system-1(Esx-1) secreted protein B (EspB) and high-temperature protein G (HtpG), which were not previously associated with CRISPR/Cas systems, are involved in mycobacterial CRISPR/Cas systems with distinct functions. Conclusion: EspB is a novel crRNA-binding protein that interacts directly with the MTB crRNP complex. Meanwhile, HtpG influences the accumulation of MTB Csm proteins and EspB and interferes with the defense mechanism of the crRNP complex against foreign DNA in vivo. Thereby, our study not only leads to developing more precise clinical diagnostic tool to quickly detect for MTB infection, but also knows these proteins merits for TB biomarkers/vaccine candidates.
Insights
Two novel proteins, EspB and HtpG, are involved in Mycobacterium tuberculosis's CRISPR/Cas system. EspB binds crRNA, while HtpG inhibits Csm protein accumulation, impacting bacterial defense mechanisms and offering potential for TB diagnostics and vaccines.
Area of Science:
- Molecular Biology
- Microbiology
- Immunology
Background:
- Mycobacterium tuberculosis (MTB) possesses a type III-A CRISPR/Cas system for defense against foreign nucleic acids.
- The specific roles and components of the MTB CRISPR/Cas system remain largely uncharacterized.
Purpose of the Study:
- To identify and characterize novel proteins involved in the MTB type III-A CRISPR/Cas system.
- To elucidate the distinct functions of identified proteins, EspB and HtpG, within this system.
Main Methods:
- Proteins EspB and HtpG were identified using Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS).
- Functional roles were assessed via plasmid interference assays and co-immunoprecipitation analyses.
- Interactions with the CRISPR RNA ribonucleoprotein (crRNP) complex and Csm proteins were investigated.
Main Results:
- EspB was identified as a novel crRNA-binding protein that directly interacts with the MTB crRNP complex.
- HtpG was found to inhibit the accumulation of MTB Csm proteins, thereby interfering with the CRISPR/Cas defense mechanism.
- Both EspB and HtpG, previously unassociated with CRISPR/Cas, play distinct roles in mycobacterial defense.
Conclusions:
- EspB is a novel crRNA-binding protein crucial for the MTB CRISPR/Cas system's function.
- HtpG modulates Csm protein levels and impacts the overall efficacy of the crRNP complex against foreign DNA.
- These findings offer potential for developing new clinical diagnostic tools and vaccine candidates for tuberculosis (TB).
Related Concept Videos
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...

